Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

759
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
759
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

953
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
953
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

467
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
467
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

684
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
684
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

387
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
387
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment outcomes of daptomycin- and vancomycin-resistant <i>Enterococcus faecium</i> bloodstream infection.

JAC-antimicrobial resistance·2026
Same author

Gut microbiome features associated with vancomycin-resistant Enterococcus acquisition in intensive care unit patients.

Annals of clinical microbiology and antimicrobials·2026
Same author

Clinical outcomes and molecular epidemiology of vancomycin-resistant Enterococcus faecium bloodstream infection: The importance of appropriate therapy and ST17 predominance.

Journal of infection and public health·2026
Same author

Outcomes and Adverse Events Among Patients with Vancomycin-Resistant Enterococcal Bloodstream Infection Treated with Daptomycin Doses Greater than 12 mg/kg.

Infectious diseases and therapy·2026
Same author

Repurposing eravacycline as an immunomodulator for immunodeficiencies driven by anti-IFN-γ autoantibodies.

Translational research : the journal of laboratory and clinical medicine·2026
Same author

Comparative in vitro activity of minocycline, tigecycline, eravacycline, and omadacycline against Acinetobacter baumannii, Stenotrophomonas maltophilia, and the Burkholderia cepacia complex.

Journal of global antimicrobial resistance·2026

Related Experiment Video

Updated: Jan 2, 2026

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
09:06

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome

Published on: December 12, 2025

322

Severe acute respiratory syndrome.

Jann-Tay Wang1, Shan-Chwen Chang

  • 1Division of Infectious Diseases, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Current Opinion in Infectious Diseases
|March 17, 2004
PubMed
Summary

Severe acute respiratory syndrome (SARS) is a highly contagious disease caused by SARS-associated coronavirus (SARS-CoV). Early identification and infection control are crucial for limiting the spread of this serious illness.

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.8K

Related Experiment Videos

Last Updated: Jan 2, 2026

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
09:06

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome

Published on: December 12, 2025

322
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.8K

Area of Science:

  • Infectious Diseases
  • Virology
  • Public Health

Background:

  • Severe acute respiratory syndrome (SARS) emerged in China in 2002, rapidly spreading globally.
  • The outbreak affected over 8,000 individuals, with healthcare workers disproportionately impacted (21%).
  • Understanding the etiology, clinical presentation, and diagnostic findings of this novel disease was critical.

Purpose of the Study:

  • To review the current understanding of SARS.
  • To detail the etiology, clinical manifestations, and diagnostic findings of SARS.
  • To inform strategies for managing and controlling SARS outbreaks.

Main Methods:

  • Literature review of emerging data on SARS.
  • Analysis of etiological agent identification.
  • Compilation of clinical, laboratory, and radiological findings.
  • Assessment of transmission dynamics and prevention methods.

Main Results:

  • Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) identified as the causative agent.
  • Human-to-human transmission primarily through close contact; preventable with barrier precautions.
  • Common symptoms: fever, cough, dyspnea; common lab findings: lymphopenia, elevated liver enzymes, CRP.
  • Radiological findings: pneumonic lesions; disease progression can lead to respiratory failure.
  • Overall case fatality rate of 9.6%; treatment remains controversial.

Conclusions:

  • SARS is a highly contagious infectious disease with significant mortality.
  • Prompt case identification and stringent infection control measures are essential to curb its spread.
  • Further research into effective treatments is warranted.